Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 19 and 80 years old (any gender)
- People who are able to attend all required study visits and follow the study plan
- People who are willing to take part and sign a consent form
- People who have been diagnosed with colon adenocarcinoma (a specific type of colon cancer) confirmed through a laboratory tissue examination
- People who have completed surgery to remove the affected part of the colon or rectum with the aim of curing the cancer
Who may not be able to join:
- People who are not able to have the full surgical removal of the colorectal cancer
- People who have a liver condition, such as chronic hepatitis B, hepatitis C, severe fatty liver, or cirrhosis
- People whose surgery would require the removal of additional organs beyond the colon or rectum
- People who also have another type of cancer, or a blood or immune system disease
- People who received any cancer treatment before their tumour removal surgery, including radiation therapy, chemotherapy, or targeted therapy
- People where, after surgery, it was found that a blood vessel in the surgical specimen could not provide a usable blood sample due to severe tumour involvement or other reasons (confirm with trial site)
- People who experienced serious complications after surgery that delayed their treatment, rated as a severity level of III or above on a standard medical scale (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Liver metastasis.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.